{[include file="_includes/_en/user_corp500_sub_js.html"]}

Zhejiang Vie Science & Technology Co., Ltd. Financial Data

Consolidated

Consolidated Balance Sheet (B/S)

(in million CNY)
  FY ended Mar. 31, 2021 FY ended Mar. 31, 2020 FY ended Mar. 31, 2019
Current assets 2,495.16 2,338.34 2,212.11
Illiquid assets 1,406.37 1,336.41 1,371.87
Total assets 3,901.53 3,674.75 3,583.97
Current liabilities 1,641.56 1,547.01 1,396.50
Illiquid debts 268.97 125.72 213.86
Total liabilities 1,910.53 1,672.73 1,610.36
Capital 479.65 479.65 479.65
Capital reserve 783.70 786.01 774.89
Profit reserve 98.05 0.10 89.94
Backlog profit 557.51 559.67 551.60
Minority stock holders' equity 72.09 78.64 77.53
Total stockholders' equity 1,991.00 2,002.02 1,973.61
Total Liabilities and shareholders' equity 3,901.53 3,674.75 3,583.97

 

Consolidated profit and loss statement

(in million CNY)
  FY ended Mar. 31, 2021 FY ended Mar. 31, 2020 FY ended Mar. 31, 2019
Sales 2,713.12 2,522.05 2,249.12
Operating profit (1.02) 87.83 133.90
Gross profit 7.87 87.01 132.05
Net profit 10.02 65.47 127.78



Consolidated Cash Flow

(in million CNY)
  FY ended Mar. 31, 2021 FY ended Mar. 31, 2020 FY ended Mar. 31, 2019
Cash flows from operating activities 48.34 113.04 202.17
Cash flows from investing activities (112.87) 14.27 (104.52)
Cash flows from financing activities 35.85 (119.36) (105.03)
Gains and losses from exchange-rate translation (2.29) (5.83) 0.97
Increases (decreases) in cash and cash equivalents (30.96) 2.12 (6.42)
Cash and cash equivalent at the beginning of the term 541.81 539.70 546.12
Cash and cash equivalents at the term-end 510.85 541.81 539.70

Non-consolidated

Unconsolidated Balance Sheet (B/S)

(in million CNY)
  FY ended Mar. 31, 2021 FY ended Mar. 31, 2020 FY ended Mar. 31, 2019
Current assets 1,299.29 1,362.20 1,295.29
Illiquid assets 1,467.59 1,442.96 1,420.35
Total Assets 2,766.88 2,805.16 2,715.64
Current liabilities 805.90 915.21 766.28
Illiquid debts 176.73 79.77 172.47
Total liabilities 982.62 994.98 938.76
Capital 479.65 479.65 479.65
Capital reserve 775.57 775.35 775.25
Profit reserve 75.54 75.54 67.42
Backlog profit 453.51 479.64 454.56
Total stockholders' equity 1,784.26 1,810.18 1,776.88
Total Liabilities and shareholders' equity 2,766.88 2,805.16 2,715.64

 

Unconsolidated profit and loss statement

(in million CNY)
  FY ended Mar. 31, 2021 FY ended Mar. 31, 2020 FY ended Mar. 31, 2019
Sales 1,245.90 1,381.40 1,182.05
Operating profit (11.91) 94.87 186.50
Gross profit (10.91) 94.01 184.66
Net profit (2.15) 81.16 176.76

 

Unconsolidated cash flow

(in million CNY)
  FY ended Mar. 31, 2021 FY ended Mar. 31, 2020 FY ended Mar. 31, 2019
Cash flows from operating activities 42.04 100.67 230.15
Cash flows from investing activities (147.12) 2.69 (118.87)
Cash flows from investing activities (15.94) (408.81) (82.69)
Gains and losses from exchange-rate translation (2.40) (6.05) 0.79
Increases (decreases) in cash and cash equivalents (123.41) (311.50) 29.38
Cash and cash equivalent at the beginning of the term 347.06 359.06 329.69
Cash and cash equivalents at the term-end 223.65 47.56 359.06
Source : The Company's annual reports (data based on Chinese accounting standards)
Fiscal years ending in Dec. 31.